[New antiretroviral agents].
In the last years significant advances in the knowledge of all aspects of HIV infection have happened. It is especially important that the new kinds of treatment against the virus have substantially improved the prognosis of the infection. The available antiretrovirals belong to three groups: nucleoside reverse transcriptase inhibitors, non nucleoside reverse transcriptase inhibitors, and protease inhibitors. We review the characteristics of the most recently developed drugs.
Roca
B
B
Unidad de Enfermedades Infecciosas, Hospital General, Castellón.
Simón
E
E
D000900:Anti-Bacterial Agents; D019380:Anti-HIV Agents / Q000145:classification / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors